20768-14-3

Basic information

• Product Name: (4-nitrophenoxy)acetic acid tert-butyl ester
• Synonyms: (4-nitrophenoxy)acetic acid tert-butyl ester
• CAS NO: 20768-14-3
• Molecular Weight: 253.255
• Mol File: 20768-14-3.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: (4-nitrophenoxy)acetic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-nitrophenoxy)acetic acid tert-butyl ester(20768-14-3)
• EPA Substance Registry System: (4-nitrophenoxy)acetic acid tert-butyl ester(20768-14-3)

Safety Data

• Hazardous Substances Data: 20768-14-3(Hazardous Substances Data)

Upstream product

• 100-02-7 4-nitro-phenol 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 107-59-5 tert-Butyl chloroacetate 
• 1798-11-4 4-nitrophenoxyacetic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 174774-57-3 tert-butyl 4-(methylamino)phenoxyacetate 
• 207445-12-3 {(S)-2-[(R)-1-(4-tert-Butoxycarbonylmethoxy-phenylcarbamoyl)-2-phenyl-ethylcarbamoyl]-pyrrolidin-1-yl}-oxo-acetic acid methyl ester 
• 207445-09-8 [4-((R)-2-Benzyloxycarbonylamino-3-phenyl-propionylamino)-phenoxy]-acetic acid tert-butyl ester 
• 209258-95-7 [(S)-2-((R)-1-{[(4-tert-Butoxycarbonylmethoxy-phenylcarbamoyl)-methyl]-carbamoyl}-2-phenyl-ethylcarbamoyl)-pyrrolidin-1-yl]-oxo-acetic acid methyl ester 
• 209258-89-9 (S)-2-[(R)-1-(4-tert-Butoxycarbonylmethoxy-phenylcarbamoyl)-2-phenyl-ethylcarbamoyl]-pyrrolidine-1-carboxylic acid benzyl ester 
• 1026251-05-7 [(S)-2-((R)-1-{[(4-Carboxymethoxy-phenylcarbamoyl)-methyl]-carbamoyl}-2-phenyl-ethylcarbamoyl)-pyrrolidin-1-yl]-oxo-acetic acid methyl ester 
• 209258-74-2 (S)-1-{(2S,3S)-2-Hydroxy-3-[2-(4-nitro-phenoxy)-acetylamino]-4-phenyl-butyryl}-pyrrolidine-2-carboxylic acid tert-butylamide 
• 170737-24-3 tert-butyl 4-(6-cyano-2-naphthalenecarboxamido)phenoxyacetate 

Relevant articles and documents

QUINOLINE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS

The present invention is directed to quinoline derivatives, pharmaceutical compositions containing said derivatives and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, in the treatment of disorders

2,4-Pyrimidinediamine Compounds and Their Uses

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

GLYCINE B ANTAGONISTS

The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.